Induced pluripotent stem cells (iPSCs) are generated via the expression of the transcription factors OCT4 (also known as POU5F1), SOX2, KLF4 and cMYC (OSKM) in somatic cells. In contrast to murine naive iPSCs, conventional human iPSCs are in a more developmentally advanced state called primed pluripotency. Here, we report that human naive iPSCs (niPSCs) can be generated directly from fewer than 1,000 primary human somatic cells, without requiring stable genetic manipulation, via the delivery of modified messenger RNAs using microfluidics. Expression of the OSKM factors in combination with NANOG for 12 days generates niPSCs that are free of transgenes, karyotypically normal and display transcriptional, epigenetic and metabolic features indicative of the naive state. Importantly, niPSCs efficiently differentiate into all three germ layers. While niPSCs can be generated at low frequency under conventional conditions, our microfluidics approach enables the robust and cost-effective production of patient-specific niPSCs for regenerative medicine applications, including disease modelling and drug screening.
P luripotent stem cells (PSCs) were derived from early embryos as embryonic stem cells (ESCs) 1, 2 and subsequently from somatic cells via transcription factor-mediated reprogramming 3 . Murine PSCs are thought to represent a naive pluripotent state, characterized by the expression of the transcription factors Oct4, Sox2, Nanog, Klf4 and Tfcp2l1 in response to the cytokine LIF and the inhibition of GSK3 and MEK kinases 4, 5 . Murine naive PSCs display low levels of repressive epigenetic modification, such as trimethylation of lysine 9 on histone 3 (H3K9me3) or cytosine methylation, and are metabolically sustained by high levels of oxidative phosphorylation 4, 5 . Importantly, murine naive PSCs efficiently generate cells of all three germ layers.
Conversely, conventional human PSCs, either derived from early embryos 2 or via the reprogramming of somatic cells using OSKM 3 , resemble a distinct, more advanced developmental stage called primed pluripotency. Primed PSCs express OCT4, SOX2 and NANOG in response to fibroblast growth factor (FGF) and transforming growth factor-β signals, display higher levels of repressive epigenetic modifications and are mostly glycolytic 4 . Different primed PSC lines display a differentiation bias towards some germ layers 6 . Recently, human naive PSCs have been generated through either the expression of transgenes together with genomic reporter constructs or directly from human embryos 5, 7 . The use of human embryos has ethical limitations and obviously does not allow the generation of patient-specific naive PSCs. Meanwhile, the conversion of somatic cells to naive pluripotency using available protocols requires one or more rounds of stable genetic manipulations, which are time-consuming, inefficient and potentially mutagenic. To overcome such limitations, we derived a strategy for the efficient generation of transgene-free niPSCs directly from somatic cells.
Results
Devising a strategy for the transgene-free generation of niPSC colonies. We have previously shown that the delivery of modified messenger RNAs (mmRNAs) encoding for OSKM, LIN28 and NANOG using microfluidics results in the rapid and efficient generation of primed iPSCs 8 . Here, we compared the global gene expression profile of primary iPSC colonies generated via microfluidics or under conventional culture conditions (CCC) and observed that several transcription factors associated with naive pluripotency were upregulated (Fig. 1a,b) . This result suggests that microfluidics could favour activation of the naive network. Therefore, we determined whether naive PSCs could be derived directly from primary somatic cells using a microfluidics approach. To test this hypothesis, we transfected BJ human fibroblasts with mmRNAs via microfluidics using our previously described setup 8 ( Supplementary Fig. 1a ), leaving out the primed pluripotency factor LIN28 (that is, using OSKMN) 9 . DPPA5, a gene highly induced in human naive cells 10, 11 , became detectable from day 14 ( Supplementary Fig. 1b) , despite the use of FGF2-containing medium for generating primed PSCs (that is, primed reprogramming medium (PRM)). The generated colonies showed the morphology of primed PSCs and lost DPPA5 expression after passaging. We then tried to sustain the expression . b, The analysis revealed an increased expression of naive-associated markers in microfluidic conditions compared to CCC. Mean ± s.e.m., n = 4 biological replicates, shown as circles. c, OSKMN-specific mmRNA transfection in the presence of PRM led to the formation of primed human iPSC colonies at day 14 (D14; bottom, left panel), expressing DPPA5 (black bar of middle panel; see also Supplementary Fig. 1b) . Exposure of primary colonies to 2iL transiently upregulated DPPA5 expression (grey bars) but did not lead to the formation of naive-like iPSCs. GAPDH served as the loading control. Bars indicate the mean ± s.e.m. of n = 3 biologically independent experiments, shown as circles. Unpaired two-tailed Mann-Whitney U-test. d, Evaluation of the effect of different inhibitors during the first 6 days in PRM. CHIR99021 (CH) promotes colony formation and facilitates efficient transfection ( Supplementary Fig. 1d ). Black bars indicate the means of technical replicates (n = 9 for untreated, n = 7 for all other conditions) pooled from 2 independent experiments, shown in two different colours. PD, PD0325901. e, Fibroblast reprogramming using PRM+ CHIR99021 for 6 days followed by 2iLGo+ KSR. Fibroblasts convert from a spindle to an epithelial-like morphology (D5). Cells become progressively compact and small colonies emerge (arrowheads). Representative pictures of eight independent experiments. f, Immunostaining of primary naive-like colonies at D15 reveals expression of naive markers and an absence of SSEA4. Representative pictures of three independent experiments. g,h, Addition of a ROCK inhibitor (Ri) and hypoxia increased both the success rate (g) and efficiency (h) of reprogramming. For g, each bar indicates the success rate of each independent experiment, calculated as the percentage of technical replicates (numbers above bars) containing naive-like colonies. of DPPA5 by providing the correct signalling environment. The cytokine LIF, the GSK3 inhibitor CHIR99021 and the MEK inhibitor PD0325901 in N2B27 medium (2iL) are present in several media for murine and human naive PSC culture 5, 7 . Switching the media to 2iL at day 14 boosted and maintained DPPA5 expression for the subsequent 8 days (Fig. 1c) . However, they were morphologically indistinguishable from colonies kept in PRM (Fig. 1c , bottom panels), and rapidly collapsed upon passaging in 2iL. We reasoned that by day 14 in PRM, iPSCs have already lost the competence to reach the naive state, so we exposed cells to 2iL from the beginning of the reprogramming protocol ( Supplementary Fig. 1c ). However, no iPSC colonies formed, and we observed fibroblast senescence, reduced transfection efficiency and failure to execute the mesenchymal-to-epithelial transition (MET) 12 , which normally occurs by day 6 ( Supplementary Fig. 1c,d ).
Direct generation of human naive induced pluripotent stem cells from somatic cells in microfluidics
Based on these observations, we devised a two-step protocol. We used PRM for the first 6 days to avoid senescence and allow MET and subsequently applied 2iL supplemented with the PKC inhibitor Gö6983 (2iLGo) and 1% knockout serum replacement (KSR), which has previously been used to enhance and stabilize human naive pluripotency 10, 11, 13 ( Fig. 1d, top panel) . During the first 6 days, we also tested the effect of adding various inhibitors; we observed the formation of several naive-like colonies under different combinations, with the most efficient condition being PRM+ CHIR99021 (Fig. 1d, bottom panel) . Under these conditions, mmRNA transfection was robust ( Supplementary Fig. 1e ), MET occurred by day 5 and was followed by the appearance of naive-like colonies from day 9 (Fig. 1e, red arrowheads) . Such colonies expressed the naive markers TFCP2L1, DPPA3 and DNMT3L (Fig. 1f) , the core factor NANOG and were negative for the primed surface maker SSEA4 14 .
The protocol appeared robust given that 89% of 213 individual microfluidic channels presented naive-like colonies (Fig. 1g,h, red) , representing an efficiency of 0.87% (that is, 0.87 colonies generated for 100 fibroblasts seeded). Inhibition of Rho-associated protein kinase (ROCK) and hypoxic conditions 15, 16 resulted in the generation of colonies in 100% of the microfluidic channels, representing an increased efficiency of 3.02% (Fig. 1g,h, purple) . We conclude that delivering OSKMN-specific mmRNAs via microfluidics facilitates the rapid and robust generation of naive PSC colonies from human fibroblasts.
Long-term expansion and characterization of naive iPSCs.
Different media and extracellular matrix proteins have been used for the culture of human naive cells 5, 7 . Cells transfected with OSKMN were cultured via microfluidics under conditions of hypoxia for 6 days in PRM+ CHIR99021+ ROCK inhibition (Ri), followed by 6 days in different naive media, such as 4iLA 17 or the commercially available RSeT (Fig. 2a) . Naive colonies, expressing OCT4 and KLF17, formed robustly in all types of media ( Fig. 2b ; Supplementary  Fig. 1g) , with an increase in colony size in RSeT medium (Fig. 2c,d ). Coating the microfluidic channels with fibronectin, Matrigel or laminin facilitated the generation of naive colonies with comparable efficiency ( Supplementary Fig. 1g,h ), indicating that our protocol can be easily adapted to different culture conditions. Next, we tested whether primary colonies could be expanded long term. To do so, we transferred them from microfluidic conditions to CCC on feeders in the respective media and under hypoxia and we succeeded in expanding them over multiple passages (Fig. 2e,f,h ). RSeT again appeared to be the most robust among the three types of media, so it was used for all further experiments.
niPSCs, either freshly derived (passage 0) or after several passages (up to passage 21), displayed robust expression of naive pluripotency markers. Moreover, they exhibited a strongly reduced expression of the differentiation marker T and of the primed pluripotency markers SSEA4, OTX2 and ZIC2, indicating that a stable naive phenotype was achieved ( Fig. 2e-h; Supplementary Fig. 2a ).
We also obtained niPSCs from four other somatic cells: human male foreskin fibroblasts (HFFs), female lung fibroblasts (WI-38 and IMR-90) and primary skin fibroblasts of an 80-year-old female donor ( Fig. 2i; Supplementary Fig. 2b-d ; Supplementary Table 1) . All these niPSC lines expressed naive markers and expanded robustly over multiple passages, retaining naive morphology and high clonogenicity (Fig. 2e ,f,j,k; Supplementary Fig. 3a,b) .
Some human naive PSC lines, derived from embryos or from primed PSCs, display chromosomal instability after extensive culture 11, 14, 18 . Using DNA staining followed by flow cytometry, we observed that all lines were diploid for the first 8 passages. A stable diploid karyotype was observed in 6 out of 8 lines for up to 42 passages. Only 2 lines (HPD01 and HPD07) showed a fraction of tetraploid cells after 12 and 23 passages, respectively ( Supplementary  Fig. 3c ). We isolated the diploid population via fluorescence activated cell sorting (FACS), and these cells then maintained a correct karyotype. A correct karyotype was also confirmed by Q-banding in five independent niPSC lines ( Fig. 2k; Supplementary Fig. 3d ). We conclude that reprogramming via microfluidics does not induce chromosomal abnormalities per se, which are instead probably due to extended culture.
A naive state transcriptome is rapidly acquired during niPSC generation. We performed transcriptome profiling of niPSCs, primed iPSCs generated via microfluidics ( Supplementary Fig.  1c ) and human fibroblasts using RNA-sequencing (RNA-seq). Unsupervised clustering based on specific markers grouped niPSCs together with other previously described human naive cells 10, 11, 17, 18 , clearly separating them from primed PSCs (Fig. 3a) . Similar results were obtained by analysing the whole transcriptome ( Fig. 3c ; Supplementary Fig. 4a ). Naive iPSCs have been recently generated from human fibroblasts via Sendai virus-mediated delivery of OSKM without a microfluidics approach 19, 20 . Depending on the media used, some of those lines grouped together with embryoderived naive PSCs and with niPSCs ( Fig. 3a,c ; Supplementary Figs. 4a-c and 8; see also Discussion).
The presence of a unique set of transposable elements expressed by cleavage-stage embryos characterize the human naive pluripotent state 17 . The transposable element profile of niPSCs was clearly distinct from those of primed cells and comparable to previously described naive PSCs (Fig. 3b) . Notably, primary colonies ("niPSCs p0" in Fig. 3a-c) collected at day 15 were transcriptionally indistinguishable from established naive PSCs. We conclude that our reprogramming strategy enables the rapid and full acquisition of a human naive transcriptome.
Next, we determined whether our system would allow the study of the trajectories of iPSC generation from fibroblasts. As proof of principle, we transfected fibroblasts with OSKMN-specific mmRNAs either under the optimized protocol (described in Fig. 2a) to generate niPSCs or in PRM to generate primed iPSCs. A gene expression analysis of a panel of naive-and primed-state markers revealed that the two reprogramming trajectories diverged significantly after day 8 ( Fig. 3d,e; Supplementary Fig. 4d ). Between days 5 and 8, cells undergo dramatic morphological changes indicative of a MET (Fig. 1e ). We measured a reduction in mesenchymal markers (Fig. 3f, grey) and a gradual activation of epithelial markers (Fig. 3f, orange) for both reprogramming protocols, indicating that MET is a common early molecular event. We conclude that our reprograming method allows the study of distinct trajectories that lead to either primed or naive pluripotency.
Global reduction in repressive epigenetic modifications in niPSCs.
Naive pluripotency is associated with a reduction in repressive epigenetic modification, such as H3K9me3 or cytosine methylation 7, 10, 14, 17, 18 . Immunostaining experiments showed that both markers were reduced in multiple niPSCs compared to primed PSCs ( Fig. 4a,b; Supplementary Fig. 5a ). Consistent with the reduced levels of 5-methylcytosine (5mC), we observed decreased levels of the DNA methyltransferases DNMT3A and DNMT3B, a dramatic increase of the catalytically inactive DNMT3L, and of the 5mC oxidases TET1 and TET2 (Fig. 4c) . We then determined the pattern of genome methylation using reduced representation bisulfite sequencing (RRBS) in five niPSC lines, three fibroblasts from which they were derived and an isogenic primed iPSC line (Supplementary Table 1 ). The global methylation levels (Fig. 4d ) and distributions ( Supplementary Fig. 5b ) of niPSCs were comparable to those of human blastocysts and other naive PSCs 10, 14, 17 . Unsupervised clustering of the methylation pattern clearly separated naive PSCs from somatic cells and primed iPSCs (Fig. 4e) . A set of promoters hypomethylated in human blastocysts compared to conventional primed human ESCs 21, 22 were found to be highly methylated in somatic and primed pluripotent cells, but hypomethylated in niPSCs, which is in line with their naive identity (Fig. 4f) .
Analysis of imprinted and X-linked genes status. DNA methylation is crucial for genomic imprinting, the phenomenon whereby either the maternal or paternal copy of a gene is expressed. A previous study 14 reported that DNA methylation is lost at imprinted loci in embryo-derived naive human ESCs; therefore, we tested whether niPSCs would have the same defects. We analysed 67 bona fide imprinted loci, divided into the following 3 classes (Fig. 5a ): placental, maternal and paternal. Placental loci, methylated in human oocytes and blastocysts, but not in somatic cells (blood) 23 , were hypomethylated in fibroblasts and remained so after reprogramming. Maternally imprinted loci lost methylation only in niPSCs, as previously reported 14 , while a fraction (5 out of 8) of paternally imprinted loci surprisingly maintained methylation in all niPSCs (Fig. 5a,b) . Loss of DNA methylation at the imprinted regions should result in the aberrant biallelic expression of the cognate transcripts. We interrogated RNA-seq data, taking advantage of annotated single nucleotide polymorphisms (SNPs) in MEG3 mRNA, and found monoallelic expression in somatic cells and biallelic expression in all naive PSCs, in agreement with its reduced methylation (Fig. 5c) .
Female naive pluripotent cells contain two active X chromosomes 24 , characterized by low levels of DNA methylation at CG-rich regions called CpG islands. CpG island methylation on the X chromosome in female niPSCs was dramatically reduced (Fig. 5d ) relative to female fibroblasts, and were comparable to levels observed in male cells. An analysis of SNPs on X-linked genes showed biallelic expression of several transcripts in female niPSCs (Fig. 5e) . Finally, high XIST expression was detected in female niPSCs compared to male niPSCs and somatic cells (Fig. 5f ), as previously reported for female naive pluripotent cells in vitro and in vivo 24 . These results indicate a reactivation of both X chromosomes in female niPSCs.
Naive iPSCs display high mitochondrial activity. Mitochondrial activity has been reported to be higher in both murine and human naive cells compared to their primed counterparts 5, 7 . We measured the mitochondrial membrane potential by tetramethylrhodamine methyl ester (TMRM) staining and it was barely detectable in primed cells (Fig. 6a) . Conversely, niPSCs displayed robust TMRM staining. Both niPSCs and reset H9 cells 10 displayed increased mitochondrial transcripts compared to primed PSCs ( Fig. 6b) and fibroblasts ( Fig. 6c) , as previously reported in murine PSCs 25 . We conclude that niPSCs display epigenetic and metabolic features consistent with a naive pluripotent state.
Characterization of the differentiation potential of niPSCs.
Recent reports have shown that some human naive PSC lines are lineage biased and fail to differentiate towards mature cell types 26, 27 , thus limiting their use for disease modelling and developmental studies. We tested the differentiation potential of three isogenic niPSC lines (HPD01, HPD03 and HPD04) to gauge the technical variability of our reprogramming system. A primed iPSC line (HPD00) was included as a control. First, we applied three different monolayer differentiation protocols and found that all three niPSC lines expressed mesoderm and endoderm markers after 6 days of differentiation, while ectoderm markers were robustly expressed around day 12 ( Fig. 7a ). As expected, primed iPSCs differentiated faster ( Supplementary Fig. 6a, top) . Second, we performed embryoid body differentiation and detected the expression of multiple markers of the three germ layers at day 22 in all 3 niPSC lines ( Fig. 7b ; Supplementary Fig. 6b ). Third, after 50 days of embryoid body differentiation ( Fig. 7c; Supplementary Fig. 6c ), we detected comparable levels of markers of mature cell types in all iPSC lines. Fourth, we directly tested the ability of niPSCs to form mature cell types, adapting protocols previously defined for primed PSCs. After 15 days of a hepatic differentiation protocol 28 , we observed polygonalshaped hepatocyte-like cells expressing the mature markers CYP3A and HNF4A, while a neuronal differentiation protocol 29 successfully generated cells positive for MAP2, TUJ1 and NeuN ( Fig. 7d,e ; Supplementary Fig. 7a,b) . Finally, all differentiation assays were repeated with an independent niPSC line (HPD06) derived from HFFs (Supplementary Figs. 6 and 7). In summary, these results demonstrate that niPSCs are pluripotent, respond to differentiation cues and are able to form mature cell types.
The confined microfluidic environment promotes establishment of naive pluripotency. Initial attempts to generate niPSCs using mmRNA under CCC failed. We reinvestigated this approach with our optimized protocol (Fig. 8a ), comparing microfluidic conditions and CCC. The generation of niPSCs via microfluidics was robust (100% of channels contained colonies, with an efficiency of 3.7 ± 1.0% and 3.1 ± 0.4% for BJ and HFF-1 cells, respectively). Conversely, in CCC, only 25% of wells contained naive-like colonies, with efficiency values of 0.2% and 0.04% for BJ and HFF-1 cells, respectively. Interestingly, a mixture of colonies displaying primed and naive morphology emerged in CCC (Fig. 8b , blue and red circles), a phenomenon never observed in the microfluidic culture conditions. These results strongly indicate that the confined microfluidic microenvironment promotes the generation of naive iPSCs over primed iPSCs, and that the culture conditions used (that is, RSeT medium with feeder cells) facilitate the propagation of different pluripotent cell types ( Supplementary Fig. 8 ). By adding the FGF receptor inhibitor PD173074, we selectively eliminated primed-like iPSCs (Fig. 8c , right) and obtained a stable niPSC line (HPD05) transcriptionally comparable to other naive iPSCs and clearly distinct from primed PSCs (Figs. 3a-c and 8d,e).
To directly test whether the confined microenvironment promotes reprogramming to the naive state, we generated microfluidic chips with channels of different heights, inside which we then reprogrammed BJ fibroblasts. At the height of 200 µ m, used in all other experiments, we obtained colonies at high efficiency, and all colonies expressed both KLF17 and OCT4 ( Fig. 8f; Supplementary Fig. 7c ). Increasing the height caused a reduction in both the number of colonies and the percentage of double-positive colonies, indicating the presence of either primed or partially reprogrammed colonies. Finally, decreasing the channel height to 100 µ m caused a reduction in colony number, which is probably due to rapid exhaustion of the culture medium. We conclude that reprogramming to naive pluripotency is enhanced with an optimal spatial confinement.
Finally, we determined whether microfluidics could also promote the conversion of primed PSCs to naive pluripotency. We generated primed H9 human ESCs expressing NANOG and KLF2 (NK2) in a doxycycline-inducible manner, as previously reported 10, 11 . Exposure to 2iL+ doxycycline led to the formation of naive colonies, with a fivefold increase when using microfluidic conditions compared to CCC (Fig. 8g) . In contrast, no naive colonies were observed under
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Fibroblasts Naive Naive 10, 11, 18, 34 , or specifically expressed in primed PSCs (for example, ZIC2, ZIC5 and SOX11) 11 or in fibroblasts (for example VIM, FN1 and CD44) 35 . The naive and primed human iPSCs (hiPSCs) generated in this study, shown in red and blue text, respectively, cluster together with previously characterized PSCs. Values displayed correspond to the gene expression level (normalized log 2 pseudocounts) scaled by the row mean. µ F, microfluidics. b, Heatmap of unsupervised clustering based on the expression of transposable elements 17 in primed and naive PSCs. Values displayed are transposon expression level (normalized log 2 pseudocounts) scaled by row mean. c, PCA of RNA-seq samples. Inset shows naive PSC lines derived in this study. As an internal control, we sequenced the transcriptome from reset H9 10 cells cultured in parallel to niPSCs. See also Supplementary Fig. 4a for a heatmap of unsupervised clustering based on the transcriptome. d-f, Gene expression analysis by qPCR of reprogramming trajectories of cells reprogrammed via microfluidics. Fibroblasts were plated at the same density and transfected with OSKMN either in PRM (blue) to generate primed iPSCs or in conditions facilitating niPSC formation (red), as in Fig. 2a . Samples were collected on D1, D5, D8, D10 and D12, and the expression of pluripotency markers was analysed. n = 2 biologically independent experiments. See also Supplementary Fig. 4d . PCA analysis (d) shows that reprogramming towards primed (P) and naive (N) pluripotency clearly diverge at D8. Expression of the indicated markers during reprogramming to either naive or primed pluripotency (red and blue, respectively; e). Reduced expression of the mesenchymal markers (grey) and gradual increase in epithelial (orange) markers at D5 and D8 during reprogramming (repro; f). For e and f, The expression relative to the highest value was calculated, and GAPDH served as the loading control. Bars indicate the means of two independent experiments, shown as circles. See Supplementary Table 5 for all individual numerical values.
conditions promoting primed pluripotency (with FGF and KSR), even under microfluidic conditions. We conclude that a confined environment promotes the activation of the naive pluripotency network, regardless of the starting cell type, but only in conditions supporting naive pluripotency.
Discussion
Microfluidics enables the manipulation of cells in a confined environment, whereby autocrine and paracrine factors are more concentrated 8 . The use of microfluidics facilitates the robust and efficient generation of naive iPSCs, reducing by several orders of magnitude the costs and number of somatic cells required. The efficiency of reprogramming in our system (3-5%) is substantially higher than those of other non-integrating methods for generating conventional human iPSCs 30 . We speculate that cells undergoing reprogramming release extracellular factors that support survival or cell fate transition. Identification of such factors could help improve the efficiency of reprogramming protocols under CCC.
Previous studies have reported the conversion of human somatic cells to naive pluripotency 10, 11, 13 , but they relied on secondary systems, viral vectors or required two rounds of reprogramming (OSKM followed by NK2) via an intermediate primed state. Our results show that it is possible to directly convert somatic cells to naive pluripotency through the transient transfection of OSKMNspecific mmRNAs. While KLF2 has previously been used to convert primed PSCs to naive pluripotency 10, 11, 17 , it was not included in our reprogramming cocktail because of the functional redundancy between KLF4 and KLF2, as observed in murine cells 31 . Correspondingly, KLF4 expression has recently been used to convert human primed PSCs to naive pluripotency 19 . While this manuscript was under revision, two studies were published reporting the generation of naive iPSCs from somatic cells via the expression of OSKM using Sendai viruses 19, 20 . In those studies, iPSCs generated in t2iLGöY (titrated 2iL plus the protein kinase C inhibitor Gö6983 and the ROCK inhibitor Y27632) or 5iLAF (a cocktail of 5 inhibitors targeting GSK3, MAPK/Erk, BRaf, Src and ROCK, plus the cytokines LIF, Activin A and FGF2) media consistently displayed a transcriptome similar to embryo-derived naive PSCs and niPSCs ( Fig. 3a,c; Supplementary Fig. 4a-c) , with robust expression of naive markers such as KLF17, TFCP2L1 and DNMT3L. Conversely, the use of RSeT medium led to variable results: in one study 19 , iPSCs generated in RSeT were transcriptionally similar to primed iPSCs (Fig. 3a,c) , while in the other study 20 , iPSC lines displayed either a naive or an intermediate phenotype, with heterogeneous expression of KLF17 ( Supplementary Fig. 4b,c) . In contrast, we used OSKMN-specific mmRNAs, microfluidic conditions and RSeT and obtained niPSCs homogeneously expressing several naive markers ( Fig. 2g,h; Supplementary Fig. 2a,b ) and displaying transcriptomes similar to other embryo-derived naive PSCs ( Fig. 3a-c; Supplementary Fig. 4a ). These disparate outcomes with RSeT medium may be due to other methodological parameters, such as the use of Sendai viruses versus mmRNAs, OKSM versus OKSMN, and CCC versus microfluidic conditions. We compared RSeT, 2iLGo and 4iLA media during naive iPSC generation via microfluidics ( Fig. 2b; Supplementary Fig. 1g ) and observed similar efficiencies regarding the formation of iPSC colonies positive for both KLF17 and OCT4. This result suggests that the confined environment promotes the acquisition of naive pluripotency and that this effect is dominant over media composition. Indeed, all three types of media facilitated the robust expansion of established niPSCs (Supplementary Fig. 8 ). To directly test the effect of the confined environment, we increased the height of the microfluidic channels ( Fig. 8f; Supplementary Fig. 7c ) and performed reprogramming under CCC rather than microfluidics. We observed that only in an optimally confined environment could we obtain a homogenous population of naive colonies at high efficiency (Fig. 8a-c) . Interestingly, using both a higher channel height and CCC, we obtained a mixed population of primed-and naive-like colonies in RSeT (Fig. 8b) , resembling the results reported in a previous study 20 . Thus, we argue that the confined microfluidic environment is instructive for the induction of naive pluripotency, and that RSeT is a more permissive medium, which allows the formation and expansion of a range of different pluripotent phenotypes under CCC.
A recent study 32 investigated the acquisition of naive pluripotency with a secondary system of in vitro-differentiated fibroblasts bearing a doxycycline-inducible OSKM cassette. A naive transcriptome was observed after 20 days of reprogramming, and transgene-independent iPSCs were obtained at day 24. In contrast, our method appears more rapid, given that by day 15 naive iPSC colonies showed a naive transcriptome ( Fig. 3a-c; Supplementary  Fig. 4a ) and a homogeneous protein expression profile of naive factors ( Figs. 1f and 2g; Supplementary Fig. 2a,b) , and could be readily expanded without further mmRNA delivery. Since the generation of primed iPSCs from fibroblasts with mmRNA was also faster than with Sendai virus 12, 30 , we suggest that the rapid and efficient generation of naive iPSCs achieved in this study is attributable to the combination of mmRNA and microfluidic technologies. It will be interesting to exploit our system to study at high resolution the trajectories followed by somatic cells towards naive pluripotency. As a proof of principle, we performed bulk analyses on fibroblasts reprogrammed to either naive or primed pluripotency and observed a common initial phase followed by two divergent trajectories (Figs. 3d,e and 8h) .
Chromosomal abnormalities in some naive PSCs have been reported 14, 17, 18 . Only two out of eight lines displayed a tetraploid fraction of cells after long-term expansion, which could be eliminated by FACS. We conclude that our method allows the generation of karyotypically normal naive PSCs, possibly due to the use of mmRNAs, which have been shown to cause the lowest number of chromosomal abnormalities compared to other non-integrating methods 30 . We argue that the prolonged expansion in culture, together with some yet unknown factors, might negatively influence genomic stability.
In conclusion, we showed that the confined microfluidic environment strongly enhances the direct conversion of somatic cells . Mesoderm and endoderm markers were detected in all lines at D6 of differentiation, while neurectoderm markers were detected at D12. n = 4 biologically independent experiments. See also Supplementary Fig. 6a . b, niPSCs form embryoid bodies (EBs). After 15 days of culture in suspension, EBs were plated on Matrigel to allow the spreading of differentiated cells for 7 days. Immunostaining confirmed the expression of markers of the three germ layers. n = 4 biologically independent experiments. See also Supplementary Fig. 6b . c, Starting from BJ human fibroblasts, we generated isogenic primed (HPD00) or naive PSCs (HPD01, HPD03 and HPD04) using mmRNAs via microfluidics. Expression of markers of the three germ layers was measured by qPCR before and after 50 days of EB differentiation. Early, mid and late markers are shown in different shades of colours. Robust and comparable induction of differentiation markers was observed in niPSCs and primed iPSCs. For each preparation, we pooled at least 15 EBs that were > 0.5 mm in size. See also Supplementary Fig. 6c . Data are expressed as the log 2 fold-change relative to the highest value. GAPDH served as the loading control. n = 2 independent experiments. d, In vitro hepatic differentiation of niPSCs generated mature polygonal hepatocyte-like cells expressing the specific markers HNF4A and CYP3A. n = 2 biologically independent experiments conducted in 2 niPSC lines. See also Supplementary Fig. 7 for similar results obtained with an independent niPSC line. e, In vitro differentiation of niPSCs in mature neurons. At D22 of differentiation, we observed cells positive for the panneuronal markers TUJ1, NeuN and MAP2. We should stress that the efficiency of hepatic and neural differentiation was higher in HPD01 and HPD06 lines, indicating the need for protocols optimized for naive PSCs. n = 2 biologically independent experiments. See also Supplementary Fig. 7 for similar results obtained with an independent niPSC line. Scale bars, 50 µ m (a,b,e and immunofluorescence in d), 100 µ m (bright-field in d). to naive pluripotency. With our technology, transgene-free niPSCs could be efficiently generated from patients, and their high clonogenic capacity will allow efficient gene editing. Conventional PSC lines display strong differentiation biases 6 and retain some somatic epigenetic features 33 . We provided evidence of prompt differentiation capacity; however, it is still an open question as to whether naive PSCs could represent a better system for the generation of differentiated cell types for therapeutic purposes or for disease modelling. Furthermore, naive PSCs represent a good model system to study early development, as exemplified by a recent study 24 of X-chromosome inactivation dynamics. Future studies comparing the epigenetic profile and differentiation potential of multiple patient-specific niPSCs and conventional primed iPSCs will reveal the full potential of human niPSCs in regenerative medicine, disease modelling and developmental studies.
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Methods
Cell culture. Naive human ESCs (reset H9; described previously 10 , generated via the transient expression of NK2 and provided by A. Smith's Lab) were cultured on mitotically inactivated mouse embryonic fibroblasts (MEFs; DR4, American Type Culture Collection) in 2iLGo medium prepared as follows: 1% N2 and 2% B27 supplements in DMEM-F12:Neurobasal medium (N2B27, all Thermo scientific) were supplemented with 1 μ M PD0325901 (Axon Medchem), 1 μ M CHIR99021 (Axon Medchem), 10 ng ml −1 human LIF (produced in-house) and 1-2 μ M Gö6983 (Axon Medchem). It was critical to titrate the concentration of each batch of Gö6983 to minimize cell stress due to accumulation of the inhibitor and to maximize the expression of naive markers. niPSCs were also generated and cultured on MEFs in the naive-supporting media 4iLA and RSeT. 4iLA medium was prepared as follows: N2B27 supplemented with 1 μ M PD0325901, 1 μ M WH-4-023 (Axon Medchem), 0.5 µ M SB590885 (Axon Medchem), 10 µ M ROCK inhibitor, 10 ng ml −1 LIF and 20 ng ml −1 activin-A. The FGF-free medium RSeT (05970, StemCell Technologies) was prepared following the manufacturer's instructions. niPSCs were passaged every 4-6 days as follows: cells were washed with phosphate buffer without Ca 2+ /Mg 2+ (PBS) and incubated with 300 µ l TripLE select (Thermo Scientific) per 12-well plate for 3 min at room temperature. N2B27 medium (700 µ l) was added to inhibit dissociation. Clusters (3-5 cells) were obtained by pipetting the entire volume twice. Cell suspensions were centrifuged at 300 × g for 4 min, resuspended in naive medium with 10 μ M of the ROCK inhibitor Y27632 (Axon Medchem) and seeded at ~300 MEFs per mm 2 . The ROCK inhibitor was used only for 24 h after passaging. The HFF cell lines BJ (passage 12) and HFF-1 (passage 18) (American Type Culture Collection), the female lung fibroblast cell lines WI-38 and IMR-90 (American Type Culture Collection), and primary skin fibroblasts of an 80-year-old female donor were cultured in DMEM with 10% fetal bovine serum (FBS; Sigma-Aldrich) before reprogramming. Somatic cells were cultured in normoxia (21% O 2 , 5% CO 2 , 37 °C), whereas pluripotent stem cells were cultured in hypoxia (5% O 2 , 5% CO 2 , 37 °C); the medium was changed daily. All cell lines were mycoplasma-negative (Mycoalert, Lonza). Low passage and karyotipically normal primed human ESCs (H9; also known as WA09) were obtained from and used under authorization from WiCell Research Institute. Primed human ESCs and iPSCs (HPD00) were cultured on Matrigel-coated (Corning) conventional plates in mTeSR1 medium (StemCell Technologies).
Microfluidic chips production. Microfluidic chips were produced as described at Nature Protocol Exchange (https://doi.org/10.1038/protex.2018.083). The standard height of each channel is 200 µ m and the area is 27 mm 2 . Each channel holds 10 µ l of medium when considering the inlet, the outlet and the culture channel itself (Supplementary Fig. 1a ).
Reprogramming.
A detailed protocol for the generation of niPSCs via microfluidics has been shared at Nature Protocol Exchange (https://doi. org/10.1038/protex.2018.083). All reprogramming experiments were performed in hypoxia conditions unless stated otherwise. Transfection of mmRNA leads to the transient production of the proteins of interest, with a peak between 12 and 24 h, and complete clearance at 42 h 12 . Thus, to guarantee stable protein expression, we transfected cells daily. Moreover, for analyses of primary colonies by immunofluorescence, quantitative PCR (qPCR) or RNA-seq, we waited at least 3 days since the last round of transfection to allow full clearance of the mmRNAs.
Microfluidic channels were coated with 25 µ g ml −1 fibronectin (Sigma-Aldrich) for 30 min at room temperature and fibroblasts were seeded at day − 1 at 25 cells per mm 2 in DMEM/10% FBS. Of note, a density of 10 cells per mm 2 , optimal for the generation of primed iPSCs 8 , did not lead to the generation of niPSCs. On day 0, 2 h before the first mmRNA transfection, we applied a medium optimized for mRNA transfection and previously used for the derivation of primed PSCs (PRM, StemMACS ReproBREW XF, Miltenyi Biotec). Where indicated, we added the ROCK inhibitor (5 μ M) and CHIR99021 (1 μ M) to the PRM. Cells were transfected daily at 9:00, and fresh PRM was given daily at 18:00. From day 6, we used a naivesupporting medium with the same regimen of transfection and fresh medium change. From days 0 to 12, media were supplemented with 200 ng ml −1 B18R (eBioscience) to suppress single-strand-RNA-induced immune responses. The transfection mix was prepared according to the StemMACS mRNA transfection kit (Miltenyi Biotec): 100 ng μ l −1 mmRNA mix of OSKMN and nuclear green fluorescent protein (with stoichiometry 3:1:1:1:1:1) was diluted in transfection buffer by mixing 10 µ l of the mmRNA mix with 30 µ l of the buffer. Transfection reagent was diluted separately in transfection buffer by mixing 3 µ l of the transfection reagent with 37 µ l of the transfection buffer. The two solutions were mixed (final volume of 80 µ l) and incubated for 20 min. For each microfluidic channel, we diluted 1.2 µ l of the transfection solution in 8.8 µ l of medium (either PRM or naive medium) and added it to the cells (corresponding to 0.28 ng mm −2 ). During the first 6 days, the dose of mmRNAs was gradually increased to facilitate expansion of fibroblasts.
For reprogramming in wells (CCC), we used the conditions described for microfluidics but increased the amount of mmRNA. For each well of a 12-well plate, we used 46.3 µ l of transfection solution in 0.8 ml of medium, which corresponds to 1.5 ng mm
Reprogramming of fibroblasts towards the primed state via microfluidics was achieved using the protocol described above, but using PRM until day 12. To allow direct comparison of the reprogramming trajectories towards primed and naive pluripotency (Fig. 3d-f) , we used the same seeding density of 25 cells per mm 2 and the same OSKMN mmRNA cocktail.
For testing the effect of different microfluidic channel heights (Fig. 8f) , the same mmRNA amount per cell was delivered daily, independently of the channel heights.
Resetting of primed H9 cells to naive was performed as described previously 10 . In brief, primed H9 cells were transfected with doxycycline-inducible NK2 piggyBac constructs on MEF feeders in DMEM-F12 supplemented with 20% KSR (Gibco) and 10 ng ml −1 bFGF (produced in-house). After selection, cells were dissociated into single cells with TrypLE and replated on day − 2 in the presence of the ROCK inhibitor for 24 h in microfluidic conditions and CCC at a density of 4 cells per mm 2 . Medium was changed daily for CCC and twice a day for microfluidic conditions. On day − 1, cells were incubated with doxycycline (1 µ g ml
; Thermo Scientific). From day 0, the medium was switched to 2iL where indicated. On day 14, cells were fixed and stained with an anti-TFCP2L1 antibody.
In vitro differentiation. For germ layer differentiation, niPSCs were seeded on 1% Matrigel-coated coverslips with 100 MEFs per mm 2 and cultured in RSeT medium for 2 days. Germ layer-specific medium was used thereafter, with daily medium changes. Ectoderm medium was used for 12 days, mesoderm medium was used for 6 days and endoderm medium was used for 6 days. Ectoderm medium consisted of knockout DMEM (Thermo Scientific), 15% KSR, 1% non-essential amino acids (NEAA), 1% L-glutamine, 0.1 µ M LDN193189 (Miltenyi Biotec) and 20 ng ml −1 hFGF2 (PeproTech); after the first 3 days, hFGF2 was replaced with 10 µ M SB431542 (Miltenyi Biotec) for 9 days. Mesoderm medium consisted of RPMI with 2% B27 (Thermo Scientific), 20 ng ml −1 hFGF2, 50 ng ml −1 hBMP4 (R&D) and 3 µ M CHIR99021 (only for the first 2 days). Endoderm medium consisted of RPMI with 2% B27, 100 ng ml −1 activin-A (PeproTech) and 3 µ M CHIR99021 (only for the first 2 days). For embryoid body culture, niPSC colonies were mechanically scratched with a tip and transferred into ultra-low adhesive wells (Corning) in the presence of DMEM, 20% FBS, 200 mM L-glutamine, 1% NEAA and 0.1 mM 2-mercaptoethanol 8 . Medium was changed every other day for 15 days before plating the embryoid bodies onto 1% Matrigel-coated glass plates (Labtek). After 5 days, adherent and spread cells were fixed for immunostaining.
Neuronal differentiation. The neuronal differentiation protocol was adapted from a previously published protocol 29 . Naive iPSCs were seeded as single cells at high density (530 cells per mm 2 ) on Matrigel-coated plates. Cells were cultured for 2 days in RSeT. On day 0, cells were cultured in N2B27, 1% NEAA, 200 ng ml −1 L-ascorbic acid (neural medium) supplemented with 20 ng ml −1 bFGF and 0.1 µ M LDN193189. Medium was refreshed daily. On day 3, medium was switched to neural medium supplemented with 0.1 µ M LDN193189 and 10 µ M SB431542. On days 4-9, the same medium was supplemented with 1 μ M all-trans retinoic acid (Sigma-Aldrich) and 1 μ M SAG (Calbiochem) and was refreshed daily. On days 10-15, medium was switched to neural medium supplemented with 5 μ M DAPT (Sigma-Aldrich) and 4 μ M SU-5402 (Sigma-Aldrich), 1 μ M all-trans retinoic acid and 1 μ M SAG (Smoothened Agonist, Calbiochem), and was refreshed daily. On day 16, cells were dissociated with TrypLE for 10 min, and 2 volumes of neural medium was added to inhibit dissociation. Cells were seeded on Matrigel-coated glass coverslips in wells and cultured in maturation medium, which is based on neural medium supplemented with 20 ng ml −1 BDNF, 10 ng ml −1 GDNF, 10 ng ml
CNTF (PeproTech) and 10 μ M of the ROCK inhibitor for the first 24 h. Fresh maturation medium was provided daily up to day 22 when cells were fixed for immunostaining.
Hepatic differentiation. The hepatic differentiation protocol was adapted from a previously published protocol 28 . Briefly, niPSCs were seeded as single cells (20 cells ). Cells were cultured for 2 days in RSeT. On day 0, cells were cultured in RPMI, 2% B27 and 3 µ M CHIR99021. The same medium with the addition of 100 ng ml -1 activin-A was refreshed on days 1-2. On days 3-8, the medium was switched to knockout DMEM with 20% KSR, 2 mM L-glutamine, 1% NEAA, 0.1 mM 2-mercaptoethanol and 1% dimethylsulfoxide (DMSO), and changed every other day. On days 9-15, cells were cultured in maturation medium, which is based on L15 basal medium, 8% FBS, 8% tryptose phosphate broth (Sigma), 10 µ M hydrocortisone (Sigma), 1 µ M insulin, 2 mM L-glutamine, 10 ng ml −1 HGF (PeproTech) and 20 ng ml −1 oncostatin-M (PeproTech). Fresh maturation medium was provided every other day.
Immunofluorescence and stainings. Immunofluorescence analysis was performed either on 1% Matrigel-coated glass coverslips in wells or in situ in microfluidic channels with the same protocol. Cells were fixed in 4% (w/v) paraformaldehyde (Sigma-Aldrich) in PBS for 10 min and blocked in 5% horse serum with 0.3% (v/v) Triton-X-100 (Sigma-Aldrich) for 1 h. Blocking buffer:PBS (1:2) was used to dilute primary antibodies (Supplementary Table 3 ). For staining for 5mC, fixed samples were permeabilized with 0.5% Triton X-100 for 1 h and treated with 2 N HCl for 30 min at room temperature to denature DNA. Samples were neutralized with PBS before blocking and antibody incubation. Secondary antibodies (Supplementary Table 3 ) were incubated at room temperature for 45 min at 1:500. Nuclei were stained with either Hoechst 33342 (Thermo Scientific) or 4,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich). For mitochondrial staining, cells were incubated with 1:50,000 TMRM and 1:20,000 MitoTracker (Thermo Scientific, T668, M7514) for 30 min in culture medium at 37 °C and washed twice in PBS before image acquisition. For EdU staining, cells were exposed to an EdU pulse of 1 h before fixation in formaldehyde for 15 min. Samples were processed using a Click-iT EdU Alexa Fluor 488 Imaging kit and counterstained with Hoechst nuclear dye (all Thermo Scientific). Fluorescence images were acquired using a Leica SP5 II confocal system or a Leica 6000B epifluorescence microscope. For alkaline phosphatase staining, cells were fixed with a citrate-acetone-formaldehyde solution and stained using an alkaline phosphatase kit (Sigma-Aldrich). Plates were scanned using an Epson scanner and scored manually.
Flow cytometry and cell sorting. Single cells in suspension were obtained by incubating samples for 5 min with TrypLE. For DNA content analysis by flow cytometry, cell pellets fixed in cold 70% ethanol were resuspended in PBS, incubated with 50 µ g ml −1 propidium iodide, and processed using a FACSCanto II (BD). For cell sorting based on DNA content, cells were resuspended in naive medium with 10 µ M of the ROCK inhibitor and 5 µ M Vybrant DyeCycle Ruby live stain (Thermo Scientific) for 30 min before sorting. Sorted samples were cultured on new MEFs with 10 µ M of the ROCK inhibitor for 24 h. See Supplementary  Fig. 3c for the gating strategy.
Karyotyping. Cells were incubated with 0.06 μ g ml −1 KaryoMAX (Thermo Scientific) in culture medium for 6 h at 37 °C. niPSCs were isolated with ReLeSR (StemCell Technologies) and resuspended in PBS before centrifugation. The pellet was resuspended in pre-warmed 75 mM KCl for 10 min at 37 °C. After centrifugation, the pellet was gently resuspended in 1 ml of freshly prepared fixative (3:1 methanol:acetic acid). This step was repeated twice. Q-banded fixed samples were analysed by Research & Innovation.
qPCR. Total RNA was isolated using a Total RNA Purification kit (Norgen Biotek), and complementary DNA was made from 500 ng using M-MLV Reverse Transcriptase (Invitrogen) and dN6 primers. For real-time PCR, SYBR Green Master mix (Bioline, BIO-94020) was used. Primers are detailed in Supplementary  Table 4 . Three technical replicates were performed for all qPCR experiments. GAPDH was used as the endogenous control to normalize expression.
RNA-seq. niPSCs were isolated from MEFs using ReLeSR. Briefly, cells were washed with PBS and then incubated with ReLeSR for 60 s. ReLeSR was then removed and cells were left with a thin film of liquid for 7 min. N2B27 medium was added and pipetted 4-5 times to detach colonies. Total RNA was isolated as above and sequenced using an Illumina NexSeq500, in 75-base pair pair-end format. Libraries were prepared following standard protocols from Illumina using a TruSeq Stranded mRNA Library kit. Expression levels for all the genes from ENSEMBL 87 were quantified using RSEM v.1.3.0 36 with STAR v.2.5.2b 37 (human genome GRCh38.p7). We built the genome index for STAR alignment using "rsem-preparereference" with options '-star-sjdboverhang' set to mean read length minus 1 according to STAR guidelines. Alignment and quantification were performed with default parameters using the stranded pair-end mode. The gene expression level quantification of 21 samples collected from publicly available datasets was performed as described for the in-house samples. The RSEM parameters were set according to the library design (mean reads length, stranded/non-stranded, paired/ single end; see Supplementary Table 2 ). We generated the final expression matrix excluding the genes that had less than 10 raw counts in at least 3 out of 34 samples. After applying this filter, we obtained the expression of 20,936 genes.
All RNA-seq statistical analyses were carried out in R environment (v.3.4.3) with Bioconductor 3.6. We computed the differentially expressed genes (DEGs) among the three groups (primed, naive, fibroblast) using edgeR 38 (function call "fit = glmQLFit(counts, design= ~group); glmTreat(fit, coef= n, lfc= 2)" where 'n' is one of the contrasts). A gene was considered a DEG when the absolute value of log 2 -fold change was > 2 and the adjusted P value was < 0.05 (p.adjust function, Benjamini-Hochberg method). Principal component analysis (PCA) was performed using log 2 -normalized pseudocounts (defined as count plus 1) with the prcomp function and default parameters using DEGs. Heatmaps were made using the log 2 -normalized pseudocounts (unless stated otherwise) with the pheatmap function from pheatmap R package (v.1.0.8, distance used 'euclidean' , 'ward' linkage, scale= 'row') on DEGs or selected markers. The raw counts were normalized using the betweenLaneNormalization function with the upper quantile method (EDAseq R package) 39 . For the comparison between our RNA-seq dataset and the DGE-seq dataset 20 presented in Supplementary Fig. 4c , we first obtained expression values in UMI per million from Supplementary Data 1 of the other study 20 , while our dataset was transformed into transcripts per million. Both datasets were quantile-normalized and z-scored by row separately, as described in the other study 20 . We merged the two datasets via the gene identification number to obtain a single dataset containing 14,944 genes. PCA was computed using the 4,606 genes obtained from intersecting the merged dataset, and the DEGs used for the RNA-seq comparison in the PCA are shown in Fig. 3c .
Transposon analysis. Transposon coordinates were downloaded from UCSC repeat masker track (hg38). We filtered out those transposons that overlap any genomic features annotated in ENSMBL 87. We aligned the raw reads using bowtie2 sensitive and end-to-end mode on the human genome GRCh38.p7. Transposon expression was quantified using bamtools multicov (v.2.26.0).
We analysed transposons with at least 20 counts per million in at least one sample. Differentially expressed transposons were identified using the edgeR R package. A transposon was considered differentially expressed when the P value was ≤ 0.05 and the log 2 -fold change was ≥ 2. Heatmaps were made using the log 2 -normalized pseudocounts scaled by row means with the pheatmap R package as describe for the RNA-seq data.
SNP analysis for imprinting and X reactivation. From the alignments, we extracted the reads with a minimum quality of 30 (samtools view -q 30 align.bam align-f.bam). Using GATK haplotypeCaller (genotyping_mode: DISCOVERY, minReadsPerAlignmentStart: 5, max_alternate_alleles: 1, stand_conf_call: 1 and filter_reads_with_N_cigar), we generated allele counts over the SNPs of dbSNP human v.b149. Non-biallelic variants as well as insertions and deletions were filtered out. Moreover, we considered only SNPs with at least ten reads in at least one sample. A SNP was considered heterozygous when the ratio of the counts between minor and major alleles was greater than 0.2 and the minor allele had at least 5 reads. A minor allele is the allele with fewer counts.
The loss of imprinting of a gene was quantified as the number of SNPs that showed heterozygosity in each gene. We called a loss of imprinting when at least two SNPs showed heterozygosity in a gene. X reactivation was quantified by selecting the heterozygous SNP from X-chromosome genes and by plotting the minor/total allele count ratios of heterozygous SNPs (defined as above). We excluded the pseudo-autosomal regions (PAR1: chrX:10,000-2,781,479 and chrY:10,000-2,781,479; PAR2: chrX:155,701,383-156,030,895 and chrY:56,887,902-57,217,415) from the analysis.
Methylation analysis. RRBS libraries were produced using an Ovation RRBS Methyl-Seq System (NuGEN) starting with 100 ng of genomic DNA extracted with a Quick-DNA Plus kit (Zymo) according to the manufacturer's specifications. Libraries were sequenced on a NextSeq 500 (Illumina) using a single-end 75-cycle high-output flow cell. Sequence reads were first trimmed using Trim Galore software (v.0.4.1, Babraham Bioinformatics, available at www.bioinformatics.babraham.ac.uk/projects/trim_galore/) to remove adapter sequences and low-quality end bases and then trimmed with a custom python script provided by NuGEN Technical Support (v.1.11) to remove any read that did not contain an MspI site signature (YGG) at the 5′ -end. Alignment of the reads onto the hg19 reference sequence and methylation calling were performed using Bismark 40 (v.0.18.1). Coordinates of differentially methylated regions were obtained from the literature 21, 23 . Subsequently, average DNA methylation levels and total coverage for each differentially methylated region were determined for all Bismarck-processed RRBS data files using R (v.3.3.3) and the methylkit package (v.0.9.5) 41 . To that end, RRBS data files were processed with the methRead function and the bismarkCoverage parameter set. Next, the regionCounts function was used to determine the number of methylated and unmethylated C residues in each of the differentially methylated regions in each sample. These values were then combined using the unite() function with the min.per.group paramater set to 1. Finally, we only retained those regions that were covered by at least five reads and computed a coverage weighted average methylation level for each region across all CpG islands that were covered. These values are plotted in Fig. 4d-f and listed in Supplemenary Table 5 along with the genomic coordinates of each genomic region on hg19.
Image analyses. Fiji 1.0 (ImageJ2) was used for image analyses. The size of niPSC colonies (Fig. 2d) was measured by delimiting a colony area and calculating the equivalent diameter as (area/π ) 0.5 (using the Shape filter plugin function). Fluorescence intensity (H3K9me3 or 5mC) across nuclei ( Fig. 4a,b ; Supplementary Fig. 5a ) was measured using the Plot Profile function. For each cell line, we selected representative fields and six nuclei were randomly chosen as described previously 10 .
Statistics and reproducibility. For statistical analyses, normality distribution was tested using D' Agostino-Pearson normality tests in Prism (Graphpad). The nonparametric Kruskal-Wallis test was used with non-normal datasets, using Dunn's correction for multiple comparisons. For datasets with n = 3 normality distribution and for which variance could not be estimated, we used the non-parametric twotailed Wilcoxon Mann-Whitney U-test, for which the asymptotic P values were calculated in R to avoid continuity correction. Tests and exact P values are reported in Supplementary Table 5 . The numbers of replicates and independent experiments are indicated in the figure legends and in Supplementary 
Data analysis
For statistical analysis we used Prism 6 (Graphpad, version 6.05). Fiji 1.0 (ImageJ2) was used for image analysis.
For RNA-Seq data analysis, expression levels for all the genes from ENSEMBL 87 were quantified using RSEM 1.3.0 (RNA-Seq by Expectation-Maximization) with STAR 2.5.2b (RNA-Seq aligner). All RNA-seq statistical analyses were carried out in R environment (version 3.4.3) with Bioconductor 3.6. We computed the differentially expressed genes (DEG) among the 3 groups (primed, naïve, fibroblast) using edgeR. Principal component analysis (PCA) was performed using log2-normalized pseudo-counts (defined as count plus 1) with prcomp function with default parameters using DEGs. Heatmaps were made using the log2-normalized pseudo-counts (unless stated otherwise) with pheatmap function from pheatmap R package (version 1.0.8), distance used 'euclidean', 'ward' linkage, scale='row') on DEGs or selected markers. The raw counts were normalized using betweenLaneNormalization function with upper quantile method (EDAseq R package). We provide in Supplementary 
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SNP analysis was performed using GATK haplotypeCaller version 3.8-0-ge9d806836 (genotyping_mode: DISCOVERY, minReadsPerAlignmentStart: 5, max_alternate_alleles: 1, stand_conf_call: 1 and filter_reads_with_N_cigar).
Libraries generated in RRBS were analysed as follow: sequence reads were first trimmed using Trim Galore software (Version 0.4.1) to remove adapter sequences and low-quality end bases and then trimmed with a custom python script provided by NuGEN Technical Support (Version 1.11) to remove any read that does not contain an MspI site signature (YGG) at the 5'-end. Reads alignment on hg19 reference sequence and methylation calling was then performed with Bismark (Version 0.18.1_dev ). Coordinates of DMRs were obtained from literature. Subsequently, average DNA methylation levels and total coverage for each DMR region was determined for all Bismarck processed RRBS data files using R (Version 3.3.3) and the methylkit package (version 0.9.5). To that end, RRBS data files were processed with the methRead function and the bismarkCoverage parameter set. Next, the regionCounts function was used to determine the number of methylated and unmethylated C's in each of the DMRs in each sample. These values were then combined using the unite() function with the min.per.group paramater set to 1.
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Sample size
Sample size calculation was not performed. Sample size was chosen based on standards in the field and is indicated in figure legends and in Supplementary Table 5 , which reports all source data for each dataset in this study. All qPCR experiments have been repeated at least two times independently, with 3 technical replicates for each experiment. All key experiments were repeated independently using different cells lines (e.g. reprogramming of 5 different somatic cell types, molecular characterization of 5 niPSC lines and differentiation of 4 different niPSC lines). For reprogramming experiments under conventional condition we performed at least two independent experiments, while for microfluidic experiments we performed up to 8 independent experiments, with 5 to 60 technical replicates. All differentiation experiments were performed at least in two biologically independent experiments, using between 2 and 4 different niPSCs lines. For RNAseq and RRBS we profiled at least 5 niPSC lines together with relevant controls.
Data exclusions We presented all data obtained, also in the case of negative results.
Replication
The main findings, such as the reprogramming of somatic cells to naive pluripotency, have been reproduced with n>400. For qPCR at least 2 independent experiments have been performed and confirmed by independent techniques (e.g. RNAseq in Fig. 3a , immunostaining in Fig. 2g -h and Supplementary Fig. 2 and qPCR for pluripotency markers in Fig. 2e-f ). For RNA-seq and RRBS we analysed 5 independently generated niPSC lines, together with relevant controls.
Randomization Randomization was not relevant. All cell lines or biological samples were analysed or treated in the same manner.
Blinding
Blinding was not applicable to reprogramming and differentiation assays, but comparable results were obtained by two distinct operators in two different laboratories. We applied blinding for RNA-seq processing and data analysis.
Reporting for specific materials, systems and methods Mycoplasma contamination Cells were routinely tested for Mycoplasma contamination. All cell lines were Mycoplasma negative.
Commonly misidentified lines
(See ICLAC register)
The cell lines used are not listed in ICLAC.
Flow Cytometry Plots
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The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Cell population abundance We sorted 2000 diploid HPD01 cells in Supplementary Fig. 3c . Reanalysis after 6 passages after Propidium Iodide staining indicated a pure diploid population.
Gating strategy
We stained diploid primed H9 hES cells (WiCell) with Vybrant DyeCycle Ruby, in order to set the gate on the G1 fraction. Such
